Serbia’s private healthcare industry is evolving beyond standalone clinics into a network-driven market attracting institutional investors, insurers and international healthcare groups. Rising private spending on healthcare, expanding employer-funded insurance coverage and growing consolidation among providers are reshaping the sector into a platform-based business model centered on integrated patient services.
- Insurance Growth Supports Healthcare Platform Expansion
- Cross-Border Investment Activity Intensifies
- International Operators and Domestic Networks Expand
- Employer-Sponsored Insurance Becomes Key Demand Driver
- Workforce Availability Emerges as Capacity Constraint
- Public Policy and EU Integration Shape Future Development
While the country’s public healthcare system remains the primary provider of care through compulsory insurance administered by the National Health Insurance Fund, private operators continue to benefit from demand for faster appointments, specialist consultations, diagnostics and treatment services.
According to the World Health Organization’s Serbia health-system profile, out-of-pocket payments represented 35.8% of current health expenditure in 2021, while voluntary health insurance accounted for less than 1% of total health spending. The combination of broad public coverage and substantial private spending has created opportunities for commercial healthcare providers.
The Competition Commission of Serbia reported in its 2025 sector inquiry that the private healthcare market has expanded significantly, supported by shorter waiting times, improved treatment conditions, modern medical equipment and increased use of employer-sponsored health insurance. The regulator also noted that voluntary health insurance increased its share of non-life insurance premiums from 6% in 2019 to 12% in 2023.
Insurance Growth Supports Healthcare Platform Expansion
The shift toward insurance-backed healthcare has strengthened the economics of larger provider networks. Healthcare groups connected to insurers and corporate clients can generate recurring patient volumes, standardize pricing, centralize procurement and expand referrals across multiple services.
The Competition Commission examined 18 market participants operating 29 private medical institutions, including 16 general hospitals and 13 health centers. The sample represented approximately 60% of Serbia’s private hospitals and health centers and accounted for roughly 40% to 50% of total private healthcare revenue. The market remains heavily concentrated in Belgrade, where more than 30% of private health centers and over 70% of private general hospitals are located.
Private healthcare institutions generated approximately RSD 34 billion in revenue in 2022, representing growth of 54% compared with 2019. The strongest annual increase occurred in 2021 as demand during the Covid-19 period accelerated patient use of private providers.
Among the largest operators, MediGroup, Bel Medic/Acibadem Bel Medic and Euromedik dominate the market. The Competition Commission stated that these three systems accounted for approximately 80% of revenues among the analyzed participants. Their revenue growth between 2019 and 2023 ranged from 47% to 143%, while revenues generated by the observed companies nearly doubled during the five-year period.
Cross-Border Investment Activity Intensifies
Private equity and strategic healthcare investors have already established a presence in the Serbian market through major transactions.
MidEuropa invested in MediGroup in 2018 and subsequently supported expansion initiatives and acquisitions before integrating the business with Romania’s Regina Maria healthcare platform. According to MidEuropa, MediGroup serves more than 1 million patients annually, completed five add-on acquisitions, expanded across inpatient and outpatient care, laboratory services, IVF and ophthalmology, and increased employee numbers by approximately 40% since 2021.
A further consolidation step occurred in 2025 when Mehiläinen, backed by CVC and Hellman & Friedman, completed the acquisition of Regina Maria and MediGroup. CVC described MediGroup as Serbia’s leading private healthcare provider, operating 100 units and employing more than 2,500 people. The combined Regina Maria–MediGroup operation generated approximately €550 million in revenue during 2024. The transaction positioned Serbia within a broader Central and Eastern European healthcare consolidation strategy linking healthcare assets across Serbia, Romania and neighboring markets.
International Operators and Domestic Networks Expand
Acibadem Bel Medic represents a strategic hospital-network model within Serbia. Bel Medic joined the Acibadem healthcare network in 2021, linking its operations to the Turkish hospital system owned by IHH/Acibadem. The Belgrade-based platform includes hospital facilities, medical centers, inpatient capacity, operating theatres, intensive care units, diagnostics and specialist services, integrating Serbia into a wider regional healthcare network.
Alongside international investors, domestic operators continue to expand. Public business-profile data for 2024 indicated that Euromedik employed more than 1,120 staff, including around 400 specialist physicians, and conducted more than 1.63 million examinations across 17 facilities. Its expansion demonstrates the continued ability of Serbian-owned healthcare providers to compete through service coverage, physician networks and brand recognition.
Employer-Sponsored Insurance Becomes Key Demand Driver
The insurance market is becoming increasingly important to private healthcare providers. The Competition Commission reported that voluntary health insurance premiums increased nearly 3.5 times between 2019 and 2023. More than 90% of premiums originated from legal entities and employers.
The regulator also found that approximately 60% of insurer payments made to private healthcare institutions over the five-year period were directed to MediGroup, Euromedik and Bel Medic.
Data from the National Bank of Serbia’s 2025 insurance-sector report showed total insurance premiums reached RSD 191.5 billion in 2025, an increase of 8.0%. Voluntary health insurance premiums rose 16.5%, increasing their share of total premiums from 9.9% in 2024 to 10.7% in 2025. Three insurance companies controlled 64.8% of the voluntary health insurance market. The trend is reinforcing healthcare providers’ roles as service partners for employers, banks, technology firms, manufacturing companies, logistics operators and foreign investors offering private health benefits to employees.
Workforce Availability Emerges as Capacity Constraint
Healthcare staffing remains a key challenge as the sector expands. The Competition Commission reported that participating providers employed 1,123 doctors in 2023, representing a 43% increase from 2019. The number of doctors engaged outside standard employment arrangements reached 2,120.
Medical staff increased by 55%, while non-medical staffing rose 70% during the same period. The 15 participants reporting activity data recorded approximately 4.3 million examinations in 2023, up 55% compared with 2019. The rapid expansion of facilities and patient volumes has increased demand for physicians, nurses and medical technicians, creating workforce pressures across the industry.
Public Policy and EU Integration Shape Future Development
The expansion of private healthcare is occurring alongside concerns about healthcare affordability. World Health Organization data indicate that 12.2% of Serbian households experienced catastrophic health spending in 2019, with medicine costs representing a significant burden for lower-income households.
Future sector development may also be influenced by Serbia’s participation in the EU4Health programme beginning in 2026. The initiative will provide both public and private healthcare entities in Serbia access to European Union health funding programs covering areas including diagnostics, treatment, cancer care, cardiovascular disease, digital health, mental health and responses to cross-border health threats.
The programme increases the importance of regulatory compliance, digital healthcare capabilities, clinical governance standards, data management and project financing across Serbia’s healthcare industry.
As public healthcare remains the dominant source of coverage and funding, private providers continue to expand in areas including diagnostics, laboratory services, specialist consultations, corporate healthcare programs, elective procedures, outpatient services and selected hospital activities. Market growth increasingly favors operators capable of combining extensive provider networks, physician access, insurance partnerships, digital systems and standardized clinical operations.
